2023-25 MIT Postdoctoral Fellowship Program for Engineering Excellence cohort announced
Thirteen postdocs join program that emphasizes community and prioritizes professional development.
Thirteen postdocs join program that emphasizes community and prioritizes professional development.
Albert Almada PhD ’13 studies the mechanics of how stem cells rebuild tissues. “Digging deep into the science is what MIT taught me,” he says.
Award honors “scientists who have made a transformational contribution toward the improvement of human health.”
Two professors and three additional alumni recognized for “dreaming up solutions to global challenges — advancing health, sustainability, and human connection.”
Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.
A new microscopy technique that enables high-resolution imaging could one day help doctors diagnose and treat brain tumors.
The MIT professor emerita and pioneering molecular biologist is being honored for her advocacy for women in science.
Twelve researchers selected as finalists for 2023-24 MIT-Royalty Pharma Prize Competition to support female entrepreneurs in biotech.
The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.
The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.
MIT Koch Institute researchers Daniel Anderson and Ana Jaklenec, plus 11 MIT alumni, are honored for inventions that have made a tangible impact on society.
Cancer nanomedicine was on display at the 2023 White House Demo Day.
MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.
MIT professor combines nanoscience and viruses to develop solutions in energy, environment, and medicine.
Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.